Could Pre-Surgery proton beams boost brain tumor outcomes?

NCT ID NCT07710040

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial investigates whether giving a short course of targeted proton radiation before surgery is safe for people with high-grade gliomas, an aggressive type of brain tumor. Nine participants will receive one of three escalating doses of proton therapy, followed by standard surgery and chemoradiotherapy. The goal is to find the highest safe dose and see if this approach improves tumor removal and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
preoperative proton stereotactic radiotherapy
What this could lead to
If successful, this approach could improve tumor control and survival for patients with high-grade gliomas by combining targeted radiation before surgery with standard treatment.
What could go wrong
This is a very early phase 1 trial with only 9 participants, so the safety and effectiveness are not yet established. There is a risk of radiation-induced toxicity, and the study may be stopped if unacceptable side effects occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Proton Therapy Department, A. Tsyb Medical Radiological Research Center - branch of the National Medical Radiological Research Center

    RECRUITING

    Obninsk, Kaluga Oblast, 249036, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.